Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, LifeStance Health Group, Inc. reported revenue of $1.42B, up 13.9% year over year. Operating margin was 1.7% and net margin 0.7%, on a free-cash-flow margin of 7.7% with capital expenditure at 2.5% of revenue. Every figure is computed directly from LFST's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $1.42B | 1.7% | 0.7% |
| FY2024 | $1.25B | -2.5% | -4.6% |
| FY2023 | $1.06B | -17.9% | -17.6% |
| FY2022 | $860M | -24.5% | -25.1% |
| FY2021 | $668M | -42.9% | -46.0% |
How does LFST compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AACG · ABSI · ACCS · ACHC · ACM · ADUS
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.